Daiichi Sankyo
Caroline Harris is an experienced professional in global project management and leadership, currently serving as Director of Global Project Management & Leadership at Daiichi Sankyo, Inc., overseeing oncology drug development programs since June 2021. Previously, Caroline held the position of Therapeutic Area Project Manager at Regeneron from November 2020 to June 2021 and served as Senior Specialist in Project Management at Merck from June 2016 to November 2020, where responsibilities included lifecycle management for oncology projects. Caroline's extensive background also includes roles at Boehringer Ingelheim, focusing on vaccine production technology transfer, bioprocess research, and quality control, alongside experience in laboratory management and microbiology from positions at Custom Fermentation, Land O Lakes, and ICI Garst. Caroline earned a Bachelor of Science degree in Animal Science from Iowa State University and has pursued additional studies in project management and virology.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.